China Practice

Davis Polk’s respected and long-established practice in China is ideally suited to keep pace with the PRC’s position as the world’s second-largest economy. We have more than 100 lawyers, including 11 partners and 16 counsel, in our Hong Kong and Beijing offices. Through our China practice, the firm is extensively involved in the region’s most significant and high-profile transactions. We are able to combine our presence and broad experience in China with a leading global practice in complex, cross-border securities, M&A and strategic investment transactions, as well as litigation matters 

Because of Davis Polk’s integrated, team-oriented approach, we are also able to apply a wide range of the firm's strengths to the matters of our Chinese clients. For example, we have world-class practices covering corporate governance, tax and executive compensation matters, all of which play a role in most of the China-related transactions on which we advise. 

Davis Polk’s China practice is a leader among international firms in developing a robust combined U.S., Hong Kong and English law platform, and in integrating the Asia-Pacific practice into our global transactional practice. The firm’s sophisticated Asia practice and our fully integrated international practices provide our Chinese clients with one of the most efficient full-service global law firms in China and Asia today. 

Capital Markets

Our international capital markets law practice in China is highly regarded and our extensive experience includes advising on a number of the largest and most complex securities offerings ever by Chinese companies.

Davis Polk is consistently ranked among the top legal advisers (as both issuers and underwriters’ counsel) for IPOs and other equity-related transactions in China, such as rights offerings. Since 2005, we have been involved in more Hong Kong-listed IPOs than any other law firm, and our experience on the largest, precedent-setting Chinese offerings is substantial.

We have one of the premier practices for high-yield and investment-grade debt offerings, convertible and exchangeable debt securities, including both secured and unsecured transactions in China. We have been, and continue to be, one of the most active advisers to Chinese issuers and their underwriters on debt capital markets offerings. We also have an excellent track record working with the Chinese government and several state-owned entities (SOEs) on their large sovereign debt programs. 

M&A

As one of the firms of choice for M&A work in China, we are renowned for our work advising on complex cross-border transactions. We also advise on both public and private M&A, joint ventures, spinoffs, privatizations, direct investments, buyouts and private equity. As more and more Chinese clients look to expand outside of China, we are able to fully support them, both locally and wherever they may seek opportunities to expand globally, including the United States, Europe, Asia, Africa and South America. We do this with smaller and more focused teams and office networks than those of our principal competitors.


China Enforcement and Compliance

Davis Polk’s Asia enforcement and litigation practice is a market leader in Asia. Since launching our global enforcement and litigation practice in Hong Kong in 2013, our team has become one of the largest and highly-regarded enforcement and litigation practices in Asia. The team in Hong Kong offers clients a unique platform of major Hong Kong/China-related regulatory, dispute resolution and litigation advice that combines our experience and reputation in these fields with an integrated team (anchored by teams in New York, London, Northern California, Paris and Washington DC) to support clients globally. Leading investment banks, multinational corporations and local conglomerates around the globe turn to us to handle a range of global enforcement and litigation matters including, but not limited, to major cross-border investigative and arbitration work and highest stakes civil and criminal litigation in China and Hong Kong. We also work side by side with major Chinese corporations to develop effective compliance programs, prepare policies and procedures to control risk, investigate potential misconduct, deal with regulatory authorities in multiple jurisdictions and devise strategies for remedial action.

Recognition

Capital Markets
  • Best Law Firm of the Year – FinanceAsia Achievement Awards 2013 and 2016
  • China Practice of the Year – IFLR Asia Awards 2016
  • Most Innovative U.S. Firm in Asia – IFLR Asia Awards 2011, 2014-2016
  • Law Firm of the Year – Chambers Asia Awards 2015
  • Best Overall International Law Firm for China Work – China Business Law Journal 2014
  • Best Financial Law Firm in Asia – FinanceAsia Achievement Awards 2013
  • Capital Markets Firm of the Year – Asian-MENA In-House Community Survey 2016

Notable Matters

Capital Markets
  • Postal Savings Bank of China. We advised Postal Savings Bank of China on its $7.4 billion IPO and listing on the Main Board of The Stock Exchange of Hong Kong Limited and an international offering in reliance on Rule 144A and Regulation S. It’s the world’s largest IPO since 2014.
  • China International Capital Corporation Limited (CICC). We advised CICC on its $927 million IPO and listing on the Main Board of The Stock Exchange of Hong Kong Limited and an international offering in reliance on Rule 144A and Regulation S.
  • Legend Holdings Corporation. We advised the underwriters on the $1.96 billion IPO and listing on the Main Board of The Stock Exchange of Hong Kong Limited and an international offering in reliance of Rule 144A and Regulation S of Legend Holdings Corporation.
  • The People’s Bank of China. We advised the underwriters in connection with the issue of RMB5 billion bonds by The People’s Bank of China.
  • China Railway Construction Corporation Limited. We advised the underwriters in connection with the $500 million Regulation S zero coupon H share convertible bonds offering by China Railway Construction Corporation Limited.  
M&A 
  • Syngenta. We are advising Syngenta on a $43 billion offer by ChemChina. This is the largest Chinese outbound transaction ever.
  • Ingram Micro. We advised Ingram Micro on its $6 billion acquisition by Tianjin Tianhai, a subsidiary of China's HNA Group.
  • Fujian Thai Hot Investment. We are advising Fujian Thai Hot Investmenton its HK$8 billion acquisitions of Dah Sing Life Assurance Company, Dah Sing Insurance Services and Macau Life Insurance Company from Dah Sing Financial Holdings and Macau Insurance Company.
  • China Resources Beer. We advised China Resources Beer on its $1.6 billion acquisition from AB InBev of SABMiller's 49% interest in China Resources Snow Breweries, a joint venture between China Resources and SABMiller and the largest brewer by volume in China.
  • Li & Fung. We are advising Li & Fung on the $350 million sale of its Asian consumer and health care distribution businesses to Dah Chong Hong Holdings.

 

Long one of the leading U.S. law practices in China, Davis Polk converted its Hong Kong office to a Hong Kong law practice in 2010, adding top-tier Hong Kong and English law capabilities. With the Hong Kong Stock Exchange emerging as the premier listing venue worldwide, this move has given our clients in China a one-stop source for highly sophisticated local and global transactional and corporate law advice. Our lawyers in Hong Kong are admitted in both New York and Hong Kong. We also have lawyers admitted in both Hong Kong and the United Kingdom.

In December 2012, Davis Polk launched its global Enforcement and Litigation practice in Hong Kong with the arrival of partners Martin Rogers and James Wadham, two of Asia’s leading litigators. This further exemplifies the firm’s strategic focus on delivering the best lawyers, providing the most critical advice, to the most sophisticated clients in the world’s major financial centers.

Read related articles: